🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study was to evaluate the safe and effective u...
Status
Completed
Location
Research Site
Start Date
2009-01
Trial ID
NCT00828204
This is an international multicenter study of tolerability, pharmacokinetic...
Status
Completed
Location
OOO "BioEk"
Start Date
2014-07
Trial ID
NCT02359877
Phase I study aiming at: * establishing the pharmacokinetic profile of int...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT02517788
The primary objective was to determine the tolerability of a new inhaled fo...
Status
Completed
Location
Hammersmith Medicines Research
Start Date
2001-01
Trial ID
NCT01863069
Treatments Being Tested
The objectives of the study are: \- comparison of the incidence and time c...
Status
Completed
Location
Multiple Locations
Start Date
2004-05
Trial ID
NCT00367484
Treatments Being Tested
The goal of this study was to evaluate the safety, tolerability and effecti...
Status
Completed
Location
Research Site
Start Date
2006-11-30
Trial ID
NCT00436826
Treatments Being Tested
Phase IV, multi-center, non-treatment, observational, registry study to det...
Status
Terminated
Location
Research Site
Start Date
2010-06
Trial ID
NCT01156298
The primary outcome of the study is to evaluate the cumulative area under t...
Status
Completed
Location
Research Site
Start Date
2014-10
Trial ID
NCT02269930
Treatments Being Tested
The primary objective of the study is to compare the immunogenicity of the ...
Status
Completed
Location
Local US Medical Information
Start Date
2005-01
Trial ID
NCT00110396
Treatments Being Tested
This is a prospective, multicenter, open label, uncontrolled, non-intervent...
Status
Terminated
Location
Please Contact the Merck KGaA Communication Center
Start Date
2017-02-09
Trial ID
NCT02949908
Treatments Being Tested